Atlas Trials

Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies

Clinical trial NCT06683365 · RECRUITING

Trial details

NCT number
NCT06683365
Sponsor
Craig van Horne, MD, PhD
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple System AtrophyParkinsons Disease
Start date
2025-02-25
Primary completion
2028-12-02
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.